106 results on '"Burkey, B.B."'
Search Results
2. Elective Neck Treatment for Clinically Node-Negative Salivary Gland Cancer: Observation, Neck Dissection, or Neck Irradiation?
3. Second Primary Head and Neck Malignancies in Patients With Prior Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) Treated With Radiation
4. Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy (H-IMRT) for Head and Neck Cancer
5. Tumor Volume As A Predictor Of Locoregional Failure In Locally Advanced Laryngeal Cancer
6. Predictors Of Locoregional And Distant Recurrence In HPV-Related Oropharyngeal Cancer Patients Treated With Cisplatin-Based Chemoradiation: A Recursive Partitioning Analysis
7. A Comparison Of Prognostic Factors For Survival After Distant Metastasis In HPV+ And HPV- Head And Neck Cancers
8. Impact of Insurance and Socioeconomic Status on HPV-related Oropharyngeal Cancer
9. Prognostic Impact of Baseline and Delta Tumor Radiomics Features in Patients With Oropharyngeal Cancer (OPC) Treated With Adaptive Image-Guided Radiotherapy (IGRT)
10. Definitive Radiotherapy for Elderly Patients with Locally Advanced Squamous Cell Head and Neck Cancer (LAHNSCC): A Single-Institution Experience
11. Time to Treatment Initiation is Associated with Clinical-to-Pathologic Upstaging in Primary Total Laryngectomy
12. Oncologic and Functional Outcomes Following Primary Total Laryngectomy
13. Updated outcomes of split course accelerated hypofractionated radiotherapy for the treatment of head and neck cancers
14. Influence of Treatment Package Time on Outcomes in High-Risk Oral Cavity Carcinoma in Patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Collaborative Study
15. Pre-Treatment Factors Predictive of Distant Recurrence after Definitive Treatment of HPV Associated Oropharyngeal Cancers
16. Treatment Breaks Are Equally Impactful Upon HPV+ and HPV- Patients Undergoing Definitive Radiotherapy: A Multi-Institution Analysis
17. Adjuvant Radiation for Pathological N1 Patients with Oral Cavity Squamous Cell Carcinoma after Adequate Neck Dissection
18. Patient Selection for De-Escalated Radiotherapy for Early-stage HPV+ Oropharynx Cancer Can be Improved by Considering Smoking Cessation: A Multi-Institution Analysis
19. Factors Predictive of Overall Survival in Metastatic HPV+ Oropharyngeal Cancer: A Multi-Institutional Study
20. Improving Prognostic Classification in Intermediate Risk (INT) Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-institutional Collaborative Study
21. Suboptimal Outcomes in Patients with Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases Treated with Surgery and Radiation Therapy
22. Loco-Regional Relapse and Predictors of Outcome in Early Stage Oral Cavity Cancers (pT1-2N0) Treated with Surgical Monotherapy with or without Neck Dissection: A Multi-Institutional Study
23. Validating the AJCC 8th Edition of the Oral Cavity Cancer Staging System: A Multi-institutional Collaborative Study
24. The Influence of Smoking and Age on Pathologic Features and Outcomes in Oral Cavity Squamous Cell Cancer: A Multi-institutional Collaborative Study
25. Supplanting the Conventional Risk Groups of Oral Cavity Cancers with Gene Expression-Based Signatures
26. Outcomes after Salvage Therapy in Oral Cavity Squamous Cell Carcinoma (OCSCC) Patients Who Developed Locoregional Failure (LRF) after Definitive Surgery and Adjuvant (chemo)Radiotherapy: A Multi-Institutional Collaborative Study
27. Head and Neck Squamous Cell Carcinoma in Organ Transplant Recipients: A Single Institutional Experience
28. Will Thyroid Avoidance Planning IMRT Reduce the Rate of Radiation-Induced Hypothyroidism and Improve Healthcare Value?
29. Suboptimal Outcomes in Patients With Cutaneous Squamous Cell Cancer of the Head and Neck With Nodal Metastases Treated With Surgery and Radiation therapy
30. Impact of Smoking on Outcomes in HPV+ Oropharynx Cancer: It′s More Than Pack-Years
31. A Matched Pair Analysis of Patients With HPV-Associated Carcinoma of Unknown Primary With T1-2 HPV-Associated Oropharynx Cancer: Implications for Clinical Trial Design
32. Tumor Volume is a Better Predictor of Locoregional Failure Than T and N Staging in Larynx Cancer Patients Treated With Definitive Chemoradiation
33. Refining Risk Stratification in HPV-Related Oropharynx Cancer: Implications for Clinical Trials
34. Successful Development, Implementation, and Assessment of a Clinical Care Path (CP) Guide for the Treatment of Human Papillomavirus (HPV)-Initiated Oropharynx Cancer
35. Clinical Predictors of Locoregional Failure in Advanced Laryngeal Cancer Treated With Definitive Chemotherapy and Radiation
36. Analyis of Prognostic Factors and Outcomes Following Parotidectomy for Cutaneous Squamous Cell Carcinoma Metastatic to the Parotid Gland
37. Validation and Comparison of Prognostic Scoring Systems in a Cohort of Human Papillomavirus–Associated Oropharynx Cancers Treated Nonoperatively
38. Commentary to 'Stomaplasty for hands-free voice with tracheoesophageal puncture' by Greg Reece
39. Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma
40. Severe Late Dysphagia and Cause of Death After Concurrent Chemoradiation Therapy for Larynx Cancer in Patients Eligible for RTOG 91-11
41. A Safety and Efficacy Comparison of High Dose Definitive (>70 Gy) Versus Postoperative Reirradiation Using Intensity Modulated Radiation Therapy (IMRT) in Recurrent or Second Primary Head and Neck Cancer
42. Primary Tumor Factors Not Lymph Node Factors Are Associated With Contralateral Failure in Resected Squamous Cell Carcinoma of the Mobile Tongue
43. Cetuximab-based Bioradiation Therapy Is Associated With Higher Rates of Distant Metastases Than Platinum-based Chemoradiation Therapy in Human Papillomavirus–Positive Oropharyngeal Cancer
44. Definitive Chemoradiation (CRT) for Organ Preservation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx (SCC-HP): Oncological Outcomes and Late Toxicity
45. Intensity Modulated Radiation Therapy (IMRT) Reduces Late Toxicity in Patients With Human Papillomavirus–Associated (HPV+) Oropharyngeal Carcinoma Treated With Chemoradiation Therapy (CRT)
46. Inferior Outcomes in Immunosuppressed Patients With High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Surgery and Radiation Therapy
47. Nasogastric Enteral Feeding Is Superior to Percutaneous Gastrostomy in Preventing Late Pharyngeal Dysfunction in Long-Term Survivors of Locoregionally Advanced Head and Neck Squamous Cell Cancer (HNSCC) Treated With Definitive Chemoradiation Therapy (CRT)
48. Reduction of Severe Late Toxicity After Definitive Chemoradiation Therapy (CRT) Using Intensity Modulated Radiation Therapy (IMRT) in Non-HPV–Associated Head and Neck Squamous Cell Carcinoma (HNSCC): More than Xerostomia
49. Risk Factors Predictive for Poor Outcomes in Patients With Human Papillomavirus (HPV)-Initiated Oropharyngeal Cancer (OPC)
50. Modest Late Toxicity and Excellent Quality of Life in Patients With Human Papillomavirus (HPV+)-Associated Oropharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy (IMRT) and Concurrent Chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.